← All indications
Mycobacterium avium-intracellulare Infection
A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis.
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (4)
Phase 2 trials (11)
Phase 1 trials (5)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (27)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Duke University
- Emory University
- University of Washington
- Johns Hopkins University
- New York University
- Oregon Health and Science University
- Stanford University
- The Oregon Clinic
- University of Iowa
- University of Kansas
- University of Miami
- University of Toronto
- Yale University
- Mayo Clinic
- University of California, San Diego
- University of California, San Francisco
- University of Chicago
- University of Colorado, Denver
- Medical University of South Carolina
- Louisiana State University
- RedHill Biopharma
- Janssen Pharmaceutica NV
- University of Texas at Houston
- University of North Carolina at Chapel Hill
- EvergreenHealth
- University of Picardie Jules Verne
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)